Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma
- 20 November 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 108 (6) , 839-844
- https://doi.org/10.1002/ijc.11638
Abstract
Astrocytomas and glioblastomas are the most frequent primary brain tumors in adults. Mutations and altered expression of multiple genes have been found to contribute to the genesis of these tumors. However, many factors in the genesis of astrocytic gliomas are not resolved yet. The frequent losses on several chromosomes indicate the role of still unidentified tumor suppressor genes. Loss of heterozygosity (LOH) on 22q has been described in up to 30% of astrocytic tumors and may be associated with progression to anaplasia. In a first step, information from the nearly finished physical sequence of chromosome 22 were used to map LOH data from 22q deletion studies on different tumor entities to identify potential tumor suppressor gene candidate regions. Next, a series of 153 astrocytic gliomas was examined with 11 polymorphic markers spanning these regions. Forty‐nine (32%) astrocytic gliomas exhibited LOH on 22q, 17 (35%) of which lost heterozygosity for all markers and 32 (65%) of which carried interstitial or partial deletions. Two regions were identified on the physical DNA sequence. The centromeric region spans 3 Mb and the telomeric region 2.7 Mb. The reduced size of these regions now allows direct analysis of all genes included. We already performed mutation analysis on 4 candidate genes from these regions (MYO18B, DJ1042K10.2, MKL1 and EP300), but did not find any mutations in astrocytic tumors.Keywords
This publication has 25 references indexed in Scilit:
- Rare mutations of the DMBT1 gene in human astrocytic gliomasOncogene, 2002
- Mutations truncating the EP300 acetylase in human cancersNature Genetics, 2000
- Mapping of a target region of allelic loss to a 0.5-cm interval on chromosome 22q13 in human colorectal cancerGastroenterology, 1999
- Truncating mutations of hSNF5/INI1 in aggressive paediatric cancerNature, 1998
- Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancerGenes, Chromosomes and Cancer, 1998
- Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 geneCancer Genetics and Cytogenetics, 1996
- Analysis of theNF2 tumor-suppressor gene and of chromosome 22 deletions in gliomasInternational Journal of Cancer, 1995
- Deletions on chromosome 22 in sporadic meningiomaGenes, Chromosomes and Cancer, 1994
- Exon scanning for mutation of the NF2 gene in schwannomasHuman Molecular Genetics, 1994
- Loss of heterozygosity for distal markers on 22q in human gliomasInternational Journal of Cancer, 1992